$IX

Ishihara Tomohiko purchased $151 of IX

Ishihara Tomohiko (Executive Officer) purchased 4 shares of ORIX CORP (IX) at $38.22 on 2026-05-20.

Original reporting
SEC EDGAR · Ishihara Tomohiko
Published Jun 25, 2026, 10:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 25, 2026, 10:36 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$IX
Neutral
high confidence
Mentioned
$IX
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IXNeutralLow
01

Why it matters

The newest fact is the reported open-market purchase by an executive officer (4 shares, $150.85 total) with holdings after the trade of 383 shares.

02

Market read

Traders may note the insider buy, but the disclosed size and lack of any accompanying corporate event make it low-impact for positioning.

03

What to watch

Insider purchases can be driven by personal liquidity/tax planning or routine compensation-related activity; without additional context, it’s not a reliable directional catalyst.

Relevance 4/10Novelty 2/10Timing: Filed 2026-06-25; transaction dated 2026-05-20.

Background

The article is an SEC Form 4 insider transaction disclosure for ORIX Corp (IX).

Company-level read

Ticker impact

$IXNeutralHigh confidence
Context

ORIX Corp insider Form 4 shows executive officer Ishihara Tomohiko bought 4 shares at $38.22 on 2026-05-20.

Expected impact

Minimal immediate price impact; more useful as a sentiment/positioning datapoint than a catalyst.

Evidence & confidence

The filing is a routine Form 4 insider transaction with small size ($150.85 total) and no 10b5-1 plan, but it does not disclose new company events, guidance, or material transactions.

Market effects

None—this is a single-company insider transaction with no sector-wide signal.

None indicated.

None indicated.

Counterpoint

The absence of a 10b5-1 plan could suggest the purchase was discretionary, but the dollar value is still too small to treat as a strong conviction signal.

Key entities

  • ORIX CORP

    Subject of the Form 4 insider transaction disclosure (IX).

  • Ishihara Tomohiko

    Executive officer who reported the open-market purchase.

Related articles

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.